Synthesis of a biotin-conjugate of Phosmidosine (cas 134966-01-1) O-ethyl ester as a G1 arrest antitumor drug

Add time:08/09/2019    Source:sciencedirect.com

This paper deals with the synthesis of a stable biotin–Phosmidosine (cas 134966-01-1) conjugate molecule 3 that is required for isolation of biomolecules that bind to phosmidosine (1). It was found that introduction of a biotin residue into the 6-N position of phosmidosine could be carried out by reaction of an N7-Boc-7,8-dihydro-8-oxoadenosine derivative 13 with phenyl chloroformate followed by displacement with a diamine derivative 6 along with the simultaneous removal of the Boc group and one of the two phenoxycarbonyl groups and the successive condensation with an N-tritylated biotin derivative 5. The condensation of an N-prolylphosphorodiamidite derivative 4 with an appropriately protected 7,8-dihydro-8-oxoadenosine derivative 17 having the biotin residue gave the coupling product 18, which was deprotected to give the biotin–phosmidosine (O-ethyl ester) conjugate 3.

We also recommend Trading Suppliers and Manufacturers of Phosmidosine (cas 134966-01-1). Pls Click Website Link as below: cas 134966-01-1 suppliers

Prev:Structure–activity relationship of Phosmidosine (cas 134966-01-1): importance of the 7,8-dihydro-8-oxoadenosine residue for antitumor activity
Next:Phototoxicity of lumidoxycycline (cas 134970-95-9))